NPC-12G Gel 0.2% Sirolimus PK Bridging Study

Clinical trial NCT03972462 · COMPLETED

Trial details

NCT number: NCT03972462
Sponsor: Nobelpharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability Study

Start date: 2019-05-31
Primary completion: 2019-06-17
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.